These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 235665)

  • 1. Effect of diphosphonate on crystallization of calcium oxalate in vitro.
    Pak CY; Ohata M; Holt K
    Kidney Int; 1975 Mar; 7(3):154-60. PubMed ID: 235665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers.
    Robertson WG; Peacock M; Marshall RW; Knowles F
    Clin Sci Mol Med; 1974 Jul; 47(1):13-22. PubMed ID: 4277691
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of diphosphonate on calcium phosphate crystallization in urine in vitro.
    Oata M; Pak CY
    Kidney Int; 1973 Dec; 4(6):401-6. PubMed ID: 4205283
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vitro and in vivo investigation of mellitate and ethane-1-hydroxy-1,1-diphosphonate in calcium phosphate systems.
    Francis MD; Slough CL; Briner WW; Oertel RP
    Calcif Tissue Res; 1977 May; 23(1):53-60. PubMed ID: 19135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates.
    Meyer JL; Lee KE; Bergert JH
    Calcif Tissue Res; 1977 May; 23(1):83-6. PubMed ID: 19137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished urinary excretion of cycle AMP by rats given disodium ethane-1-hydroxy-1,1-diphosphonate.
    Goulding A; McChesney R; Malthus RS
    J Endocrinol; 1975 Apr; 65(1):145-6. PubMed ID: 167091
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
    Walton RJ; Russell RG; Smith R; Warner G
    Clin Sci Mol Med; 1974 Sep; 47(3):13P-14P. PubMed ID: 4213811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine.
    Hayashi Y; Kaplan RA; Pak CY
    Metabolism; 1975 Nov; 24(11):1273-8. PubMed ID: 241892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation of calcium oxalate crystals: effect of urine and various inhibitors.
    Felix R; Monod A; Broge L; Hansen NM; Fleisch H
    Urol Res; 1977; 5(1):21-8. PubMed ID: 16372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
    Russell RG; Fleisch H
    Clin Orthop Relat Res; 1975 May; (108):241-63. PubMed ID: 166785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of calcium oxalate crystals. I. A model for urinary stone growth.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):31-5. PubMed ID: 1140917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
    Wesson JA; Worcester E
    Scanning Microsc; 1996; 10(2):415-23; 423-4. PubMed ID: 9813620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
    Walton RJ; Russell RG; Smith R
    Clin Sci Mol Med; 1975 Jul; 49(1):45-56. PubMed ID: 807449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direct measurement of inhibitory capacity to crystal growth of calcium oxalate in undiluted urine and in other inhibitor containing solutions.
    Baumann JM; Wacker M
    Urol Res; 1980; 8(3):171-5. PubMed ID: 6252673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.
    Pak CY; Holt K
    Metabolism; 1976 Jun; 25(6):665-73. PubMed ID: 1272073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and oxalate concentrations in human renal tissue: the key to the pathogenesis of stone formation?
    Hautmann R; Lehmann A; Komor S
    J Urol; 1980 Mar; 123(3):317-9. PubMed ID: 7359626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats.
    Trechsel U; Schenk R; Bonjour JP; Russell RG; Fleisch H
    Am J Physiol; 1977 Mar; 232(3):E298-305. PubMed ID: 402823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.